MENU
+Compare
MXCT
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$2.23
Change
-$0.01 (-0.45%)
Capitalization
450.26M

MXCT MaxCyte Forecast, Technical & Fundamental Analysis

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development... Show more

MXCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MXCT with price predictions
Jul 03, 2025

MXCT saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for MXCT moved out of overbought territory on July 01, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 46 similar instances where the indicator exited the overbought zone. In of the 46 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MXCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on MXCT as a result. In of 64 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MXCT just turned positive on June 23, 2025. Looking at past instances where MXCT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MXCT advanced for three days, in of 188 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.879) is normal, around the industry mean (24.504). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (10.482) is also within normal values, averaging (43.111).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MXCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MXCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MXCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MXCT is expected to report earnings to fall 4.20% to -9 cents per share on August 06

MaxCyte MXCT Stock Earnings Reports
Q2'25
Est.
$-0.10
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.03
The last earnings report on May 07 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 161.33K shares outstanding, the current market capitalization sits at 450.26M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
9713 Key West Avenue
Phone
+1 301 944-1700
Employees
143
Web
https://www.maxcyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEEFX81.150.91
+1.13%
T. Rowe Price Tax-Efficient Equity I
CCQYX15.510.14
+0.91%
Columbia Disciplined Core Inst3
POGSX86.220.66
+0.77%
Pin Oak Equity
JDVZX16.480.05
+0.30%
JPMorgan Diversified R6
IAFEX13.79N/A
N/A
FI Instl Grp All Frgn Eq Env & Scl Val

MXCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MXCT has been loosely correlated with RVTY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MXCT jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MXCT
1D Price
Change %
MXCT100%
-0.22%
RVTY - MXCT
44%
Loosely correlated
+0.41%
LAB - MXCT
43%
Loosely correlated
-1.46%
A - MXCT
43%
Loosely correlated
+0.60%
CERS - MXCT
43%
Loosely correlated
-1.28%
BRKR - MXCT
43%
Loosely correlated
-0.02%
More